NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
Alan Brown, MD, FACC, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of “A Focused Update to the 2019 NLA Scientific Statement On…
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association
This joint expert review provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk.
Diabesity
Case Study: Incident Type 2 Diabetes Mellitus following Statin Initiation in Youth
The association of statin use, and incident type 2 diabetes (T2D) is well established in adults. Similar observations have not been reported in youth. Despite…
Dyslipidemia Management in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Nonalcoholic fatty liver disease (NAFLD) is the accumulation of hepatic fat in ≥ 5% of hepatocytes in the absence of other etiologies of liver disease….
Lipid Management in Pregnancy and Lactation
Normal pregnancy is characterized by physiologic increases in maternal levels of cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). These lipoproteins are…
Lipid Management in Chronic Kidney Disease
Chronic kidney disease (CKD) ranks among the top five causes of global mortality, affecting approximately 35.5 million people in the United States (US). Despite being…